Results for rel:amoydiagnostics.com
-
heinrich-corless.net
Heinrich and Corless Laboratories - Cancer Research, Genetic Screening, Mutation Analysi
A joint OHSU and Portland VA cancer research lab specializing in oncogenic mutation detection and development of novel assays for treatment of human cancers
-
amoydiagnostics.com
Genetic Test For Cancer,JAK 2 Mutation Assay,FFPE DNA Extraction Kit
Want To Get More Information About Molecular Diagnostic Products And Services? AMOY DIAGNOSTICS CO.,LTD Will Be Your Best Choice. Best Cancer Detection Kit And Tissue DNA Extraction Kit Are Waiting For You!
-
previve.com
Previve - Threatened by cancer because of the brca1 genetic mutation, Claudia Gilmore docu
PREVIVE, a new documentary web series to be released in the Fall of 2010, will chronicle Claudia Gilmore's extraordinary journey to defy her destiny by
-
dsfmoleculardiagnostics.com
Home - High Throughput Mutation Screening for Cancer, Microbes and Drug Resistance
GeneMuDx's newly patented invention, DSF-applied assay, permits simultaneous analysis of hundreds genes in hundreds samples. Researchers are invited to join us to form profit-sharing joint ventures.
-
brca.fr
Cancer du sein et hérédité, mutation BRCA1 BRCA2
Site d'informations sur les formes familiales de certains cancers du sein et de l'ovaire. Comment savoir en cas de doute sur cette hérédité ? Que faire ?
-
diacarta.com
DiaCarta
DiaCarta provides innovative gene mutation testing technologies to improve the effectiveness of cures for cancers such as cervical cancer and head and neck cancer. DiaCarta’s NRAS and KRAS mutation test kits are high precision and widely used by hospitals
-
dailyhealthplus.com
Daily Health Plus
Daily Health News Magazine - Read about Vaccine, diabetes mellitus, passive smoking, Breast Cancer, Mutation
-
genemutationscreening.com
DSF Molecular Diagnostic Lab - Assays for Cancer, Leukemia and Lymphomas
DSF molecular diagnostic lab introduces two novel technologies, DSE and DSF, for sensitive and high throughput mutation screening for early detection of cancer, mrd and drug resistance. Physicians, pathologists and international investors are invited for
-
mutationscreening.com
DSF Molecular Diagnostic Lab - Home
DSF Diagnostics offers state-of-the-art molecular assays for early detection of cancer, MRD and drug resistance. Our proprietary DSE and DSF assays permit sensitive and high throughput gene mutation detection, thus ideal for large scale studies. These two
-
bcmexome.com
Cancer Genetic Test & Whole Exome Sequencing Houston, TX | Cancer Exome Sequencing
We offer next generation sequencing panels and cancer exome sequencing for mutation analysis, along with conventional single gene assays.
-
ariellamft.com
ariella goodwine mft the peninsula san mateo therapy counseling
Ariela Goodwine, MFT specializes in working with adolescents and their families, addiction treatment, and supporting breast cancer survivors/BRCA mutation carriers.
-
apobec3.com
Apogen Biotechnologies, Inc. – Breaking resistance and promising to revolutionize cancer
Breaking drug resistance in cancer, through the development of a new class of therapies, that target key drivers of ongoing DNA mutation and tumor evolution.
-
apobec3b.com
Apogen Biotechnologies, Inc. – Breaking resistance and promising to revolutionize cancer
Breaking drug resistance in cancer, through the development of a new class of therapies, that target key drivers of ongoing DNA mutation and tumor evolution.
-
apobiotech.com
Apogen Biotechnologies, Inc. – Breaking resistance and promising to revolutionize cancer
Breaking drug resistance in cancer, through the development of a new class of therapies, that target key drivers of ongoing DNA mutation and tumor evolution.
-
apogen-biotech.com
Apogen Biotechnologies, Inc. – Breaking resistance and promising to revolutionize cancer
Breaking drug resistance in cancer, through the development of a new class of therapies, that target key drivers of ongoing DNA mutation and tumor evolution.
-
apogenbio.com
Apogen Biotechnologies, Inc. – Breaking resistance and promising to revolutionize cancer
Breaking drug resistance in cancer, through the development of a new class of therapies, that target key drivers of ongoing DNA mutation and tumor evolution.
-
apogenbiomed.com
Apogen Biotechnologies, Inc. – Breaking resistance and promising to revolutionize cancer
Breaking drug resistance in cancer, through the development of a new class of therapies, that target key drivers of ongoing DNA mutation and tumor evolution.
-
apogenbiopharma.com
Apogen Biotechnologies, Inc. – Breaking resistance and promising to revolutionize cancer
Breaking drug resistance in cancer, through the development of a new class of therapies, that target key drivers of ongoing DNA mutation and tumor evolution.
-
apogenbiopharmaceuticals.com
Apogen Biotechnologies, Inc. – Breaking resistance and promising to revolutionize cancer
Breaking drug resistance in cancer, through the development of a new class of therapies, that target key drivers of ongoing DNA mutation and tumor evolution.
-
apogenbiotech.com
Apogen Biotechnologies, Inc. – Breaking resistance and promising to revolutionize cancer
Breaking drug resistance in cancer, through the development of a new class of therapies, that target key drivers of ongoing DNA mutation and tumor evolution.
-
apogenbiotechnologies.com
Apogen Biotechnologies, Inc. – Breaking resistance and promising to revolutionize cancer
Breaking drug resistance in cancer, through the development of a new class of therapies, that target key drivers of ongoing DNA mutation and tumor evolution.
-
brca1test.com
Risk Assessment
Find out if you may have an increased risk of breast cancer due to a BRCA1 or BRCA2 genetic mutation. Our hereditary cancer quiz is easy to complete
-
brca2test.com
Risk Assessment
Find out if you may have an increased risk of breast cancer due to a BRCA1 or BRCA2 genetic mutation. Our hereditary cancer quiz is easy to complete
-
brcagenetest.com
Risk Assessment
Find out if you may have an increased risk of breast cancer due to a BRCA1 or BRCA2 genetic mutation. Our hereditary cancer quiz is easy to complete
-
breaking-resistance.com
Apogen Biotechnologies, Inc. – Breaking resistance and promising to revolutionize cancer
Breaking drug resistance in cancer, through the development of a new class of therapies, that target key drivers of ongoing DNA mutation and tumor evolution.
-
breastgenetest.com
Risk Assessment
Find out if you may have an increased risk of breast cancer due to a BRCA1 or BRCA2 genetic mutation. Our hereditary cancer quiz is easy to complete
-
dna-mutation.com
Apogen Biotechnologies, Inc. – Breaking resistance and promising to revolutionize cancer
Breaking drug resistance in cancer, through the development of a new class of therapies, that target key drivers of ongoing DNA mutation and tumor evolution.
-
dsfdiagnostics.com
DSF Molecular Diagnostic Lab - Services
DSF molecular diagnostic lab offers our proprietary DSE and DSF assays for sensitive and high hroughput mutation screening assays for cancer genes. These two innovative technologies are soon entering the national phase of PCT patent application. We are se
-
genemutationtest.com
Risk Assessment
Find out if you may have an increased risk of breast cancer due to a BRCA1 or BRCA2 genetic mutation. Our hereditary cancer quiz is easy to complete
